Back to top
more

Motus GI (MOTS)

(Delayed Data from OTC)

$0.12 USD

0.12
91,468

+0.02 (23.84%)

Updated May 24, 2024 12:17 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 249)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

UnitedHealth (UNH) Unveils its Latest Outlook: Key Takeaways

by Zacks Equity Research

UnitedHealth (UNH) expects the top line to be within the range of $400-$403 billion in 2024.

Here's Why Investors Should Hold Cigna (CI) Stock for Now

by Zacks Equity Research

Cigna (CI) expects total medical customer growth to be a minimum of 1.4 million this year.

Cue Health Inc. (HLTH) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 3.77% and 10.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Invitae (NVTA) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Invitae (NVTA) delivered earnings and revenue surprises of 18.92% and 0.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

New Strong Buy Stocks for July 21st

by Zacks Equity Research

TRDA, LPRO, TBBK, BMTX and MOTS have been added to the Zacks Rank #1 (Strong Buy) List on July 21, 2023.

Motus GI Holdings, Inc. (MOTS) Upgraded to Strong Buy: Here's What You Should Know

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 38.68% and 88.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 86.67% and 5.27%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 36.80% and 72.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Holdings, Inc. (MOTS) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.63% and 14.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Olink Holding AB publ Sponsored ADR (OLK) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 91.67% and 9.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Talkspace, Inc. (TALK) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Talkspace, Inc. (TALK) delivered earnings and revenue surprises of 15.38% and 2.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of 20% and 14.19%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Holdings, Inc. (MOTS) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 25% and 12.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Holdings, Inc. (MOTS) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Lag Estimates

by Zacks Equity Research

AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Will Motus GI Holdings, Inc. (MOTS) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0% and 27.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Strata Skin Sciences, Inc. (SSKN) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 33.33% and 0.83%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of -13.16% and 25.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Holdings, Inc. (MOTS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Motus GI Holdings, Inc. (MOTS) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.09% and 20.48%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?